• Is the German drugs policy failing?

    During the joint press conference of the German-based NGOs “accept e.V.” and “Deutschen AIDS-Hilfe” on 5 July 2019, experts call for evidence-based strategy instead of party politics.

  • Cancer drug used to treat pulmonary hypertension

    Prof. Dr. Friedrich Grimminger and Prof. Dr. Ralph Schermuly from the Department of Medicine at the Justus-Liebig-Universität Gießen (JLU) report on the identification of a molecular mechanism that controls the disease from the vessel wall.

  • Better cancer treatment and vaccines through gold nanoparticles

    Gold nanoparticles could contribute to increased efficiency in the development of vaccines and drugs that target B cells, a new study concludes.

  • New Alzheimer blood test almost ready for everyday use

    In a recent study, Swedish researchers have developed a blood test that accurately detectsAmyloid beta peptides levels in all stages of Alzheimer's disease. According to their own statement, the scientists achieve "a precision that makes the test usable worldwide for everyday clinical use".

  • Multiple sclerosis due to childhood viral diseases

    Researchers at the Université de Genève have gained new insights into multiple sclerosis. In one study, they identified a potential link between viral infections in childhood and an increased risk of autoimmune diseases in adulthood.

  • Efficacy study for Huntington's drug made possible

    The potential Huntington's drug RG6042 has shown in a placebo-controlled clinical study with 46 patients to not cause any serious side effects while reducing the amount of the harmful protein huntingtin in the spinal fluid depending on the dose.

  • €4.1 million funding for Ewing sarcoma study

    German Cancer Aid (in German: Deutsche Krebshilfe) is providing scientists at the Medical Faculty of the University of Duisburg-Essen (acronym: UDE) and the Children's Hospital III of the University Hospital Essen with 4.1 million euros for a study to further help young patients of Ewing sarcomas.

  • Surprising differences in colorectal cancer cells discovered

    Scientists from the German Cancer Consortium (German acronym: DKTK) at the Charité - University Hospital of Berlin have succeeded in describing the effects of characteristic gene mutations at the individual cells level. This experimental approach could open up new colorectal cancer treatment options.

  • Measuring urban air pollution on cycle paths

    Air pollution is a global challenge that causes millions of premature deaths every year in both developing and industrialized countries. Air pollution is particularly high in urban agglomerations. A team at Germany-based IASS center is investigating urban pollutant concentrations and air quality.

  • Molecular tumor classification through AI

    For targeted colorectal cancer therapy, the treating physicians need information about the tumor’s molecular subtype. Computers could analyze digital tissue images for this purpose.

  • Telltale language: Facebook as a diagnostic tool?

    More than two billion people use Facebook to share personal stories, thoughts, and updates within their networks. A recent study has now tried to gather more data on the possible health problems of users by using their language and status messages.

  • Mobile phones as germ carriers in medical settings

    Forty percent of mobile phones used by students in health care professions are contaminated with germs. At the top of the list are Staphylococcus aureus, a problematic germ in the clinical environment and the main cause of nosocomial infections in Germany.

  • Do doctors have a higher risk of stroke?

    People who work longer than ten hours a day have a significantly increased risk of stroke, according to a recent study from France. In addition to office workers, physicians are also a risk group due to overtime and extra workload.

  • A rise in chronic hepatitis B cases

    Every second hepatitis B infection reported in the EU is now a chronic infection. The upward trend in the number of cases observed in 2008 is thus continuing.

  • When the sun cream gets into the blood

    Those who use sun lotion four times or more a day enrich the blood with ingredients of the protective agent which, according to a recent toxicological study, are at least worth checking.

  • From blood group A to O

    Researchers from Canada have succeeded for the first time in generating blood group 0 from blood group A using microbial enzymes.

  • A new antibiotics class proves highly effective

    A new class of antibiotics proved to be extremely effective against multi-resistant pathogens. The so-called fibupeptides inhibit the energy metabolism of bacteria by destroying the electrical potential of biomembranes.

  • The opioid epidemic: Is it only about the USA? (Part IV)

    The "Pasimafi" investigation did not translate into a revision of the law that Dr. Fanelli helped to draft in Italy. For many, the investigation should not halt a law that protects and guarantees access to palliative care and pain therapy for the first time in Italy.

  • The opioid epidemic: Is it only about the USA? (Part III)

    The "Pasimafi" investigation brought over fifty people and ten companies to justice. At the center of this was Dr. Guido Fanelli, a medical icon of pain therapy. The scandal extended to Mundipharma, the international arm of Purdue Pharma.

  • The opioid epidemic: Is it only about the USA? (Part II)

    The opioid crisis in the United States has killed more than 200,000 people. Behind this, the fingers point to the pharmaceutical giant Purdue Pharma

  • 71 |
  • 72 |
  • 73 |
  • 74 |
  • 75 |
  • 76 |
  • 77 |
  • 78 |
  • 79 |
  • 80 |
  • 81 |